Evaluation of Cancer Care Coordination in the National Cancer Institutes' Community Cancer Center Programs
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
-Coordinated cancer care provided by doctors, nurses, social workers, and other care providers is believed to improve patient and physician satisfaction and patient evaluation for enrollment in clinical trials. But no research has been done to show that this approach improves patient experiences and outcomes. Researchers want to study this model to better understand how it can improve cancer treatment and patient outcomes.
Objectives:
- To assess the relationship between coordinated care and cancer treatment processes and outcomes.
Eligibility:
- Individuals who are at least 18 years of age. Those who take part must have been diagnosed with colon, rectal, or non-small-cell lung cancer. They also must be receiving or have been treated at one of the 16 NCI Community Cancer Center program sites.
Design:
- Researchers will collect medical records data from participants.
- Participants will complete a questionnaire about 8 weeks after the end of all planned cancer treatment. They will be asked questions about their experience with coordinated cancer care. They will also be asked for any comments or concerns they had during and after treatment.
- No treatment or additional tests will be provided as part of this protocol.
| Condition |
|---|
|
Non-Small Cell Lung Cancer (Stage III) Colon Cancer (Stage II & III) Rectal Cancer (Stage III) |
| Study Type: | Observational |
| Official Title: | Quality of Care: The Impact of Multidisciplinary Care on Processes and Outcomes of Cancer Care |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Stage III colon cancer, Stage II or III rectal cancer or Stage III lung cancer. Additional inclusion criteria: Age: equal to or greater than 18 at time of diagnosis; English speaking (native or non-native); First or only cancer diagnosis; All or part of first course of treatment was performed at the reporting facility.
Contacts and Locations| United States, Maryland | |
| National Cancer Institute (NCI), 9000 Rockville Pike | |
| Bethesda, Maryland, United States, 20892 | |
| Principal Investigator: | Kathleen Castro, R.N. | National Cancer Institute (NCI) |
More Information
Publications:
| ClinicalTrials.gov Identifier: | NCT01346280 History of Changes |
| Other Study ID Numbers: | 999911145, 11-C-N145 |
| Study First Received: | April 29, 2011 |
| Last Updated: | February 12, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Adherence to Evidence-Based Guidelines Multidisciplinary Care Patient Experiences Quality of Care Outcomes |
Additional relevant MeSH terms:
|
Colonic Neoplasms Rectal Neoplasms Carcinoma, Non-Small-Cell Lung Lung Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms Digestive System Diseases |
Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases Carcinoma, Bronchogenic Bronchial Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 22, 2013